Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
- cleaning
- food
- industrial
- pharma
Sodium phosphate, monobasic, monohydrate
CAS 10049-21-5
Concern score
Not assessed — no hazard data yet.
Why it's flagged
EPA CPDat observed this chemical in 98 composition records across product categories including Laboratory supplies, Pet and animal care, Specialty occupational products.
Regulation
No restrictions found. Sodium phosphate, monobasic, monohydrate appears in these published regulatory listings.
- commercial_presence
- consumer_product_presence
- cpdat_category:cleaning|pharma|food|industrial
- currently_marketed_ndc
- definition_level:complete
- definition_type:primary
- inactive_ingredient_database
- ingredient_type:ingredient substance
USFDAinactive ingredient database36 entries — 13 administration routes
- Route: INTRA-ARTICULAR; Dosage form: INJECTION; Maximum daily exposure: 14 mgSource →
- Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 13 mgSource →
- Route: INTRALESIONAL; Dosage form: INJECTION; Maximum daily exposure: 14 mgSource →
- Route: INTRALESIONAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 13 mgSource →
- Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 120 mgSource →
- Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 1.84 mgSource →
- Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 15.55 mgSource →
- Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 13 mgSource →
- Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 30 mgSource →
- Route: INTRASYNOVIAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 13 mgSource →
- Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: 0.15 mgSource →
- Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 120 mgSource →
- Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 13.61 mgSource →
- Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 15.55 mgSource →
- Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 27 mgSource →
- Route: INTRAVESICAL; Dosage form: SOLUTION; Potency: 0.12 mgSource →
- Route: INTRAVITREAL; Dosage form: INJECTION; Potency: 0.86 %w/vSource →
- Route: INTRAVITREAL; Dosage form: INJECTION, SUSPENSION; Potency: 0.04 %w/vSource →
- Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 4 mgSource →
- Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 8 mgSource →
- Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.04 %w/wSource →
- Route: ORAL; Dosage form: CAPSULE; Potency: 600 mgSource →
- Route: ORAL; Dosage form: INJECTION; Potency: 10.06 mgSource →
- Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 1500 mgSource →
- Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 104 mgSource →
- Route: ORAL; Dosage form: SYRUP; Potency: 20.6 mg/5mlSource →
- Route: ORAL; Dosage form: TABLET; Potency: 31.72 mgSource →
- Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 35 mgSource →
- Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 0.11 mgSource →
- Route: SOFT TISSUE; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 13 mgSource →
- Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 2 mgSource →
- Route: SUBCUTANEOUS; Dosage form: SUSPENSION; Potency: 0.07 %w/vSource →
- Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 10 mgSource →
- Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 8 mgSource →
- Route: TOPICAL; Dosage form: LOTION, AUGMENTED; Maximum daily exposure: 10 mgSource →
- Route: TOPICAL; Dosage form: SOLUTION; Potency: 0.46 %w/vSource →
USEPAcommercial use observedEPA CPDat observed this chemical in 98 composition records across product categories including Laboratory supplies, Pet and animal care, Specialty occupational products.
- EPA CPDat observed this chemical in 98 composition records across product categories including Laboratory supplies, Pet and animal care, Specialty occupational products.Source →
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 48 active drug products and 49 total products.
- FDA NDC lists this ingredient in 48 active drug products and 49 total products.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
- openFDA substance registry classifies this ingredient as chemical.Source →
Evidence
No graded sources yet for Sodium phosphate, monobasic, monohydrate. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
Where it appears
Prevalence of Sodium phosphate, monobasic, monohydrate in our catalog (epa_cpdat).
Products
98
Laboratory suppliesPet and animal careSpecialty occupational productsFood and drugCleaning and safety
See products using Sodium phosphate, monobasic, monohydrate →
